- Home
- TSAT vs CV Comparison
TSAT vs CV Comparison
Compare TSAT & CV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- CV
- Stock Information
- Founded
- TSAT 1969
- CV 2005
- Country
- TSAT Canada
- CV United States
- Employees
- TSAT N/A
- CV N/A
- Industry
- TSAT Metal Fabrications
- CV
- Sector
- TSAT Industrials
- CV
- Exchange
- TSAT Nasdaq
- CV NYSE
- Market Cap
- TSAT 233.1M
- CV 194.2M
- IPO Year
- TSAT 1996
- CV 2025
- Fundamental
- Price
- TSAT $26.47
- CV $4.54
- Analyst Decision
- TSAT
- CV
- Analyst Count
- TSAT 0
- CV 0
- Target Price
- TSAT N/A
- CV N/A
- AVG Volume (30 Days)
- TSAT 179.5K
- CV 1.0M
- Earning Date
- TSAT 08-13-2025
- CV 01-01-0001
- Dividend Yield
- TSAT N/A
- CV N/A
- EPS Growth
- TSAT N/A
- CV N/A
- EPS
- TSAT N/A
- CV N/A
- Revenue
- TSAT $372,642,710.00
- CV $12,044,000.00
- Revenue This Year
- TSAT N/A
- CV N/A
- Revenue Next Year
- TSAT N/A
- CV N/A
- P/E Ratio
- TSAT N/A
- CV N/A
- Revenue Growth
- TSAT N/A
- CV 20.54
- 52 Week Low
- TSAT $7.21
- CV $3.49
- 52 Week High
- TSAT $27.73
- CV $5.72
- Technical
- Relative Strength Index (RSI)
- TSAT 67.61
- CV N/A
- Support Level
- TSAT $23.20
- CV N/A
- Resistance Level
- TSAT $27.73
- CV N/A
- Average True Range (ATR)
- TSAT 1.37
- CV 0.00
- MACD
- TSAT -0.06
- CV 0.00
- Stochastic Oscillator
- TSAT 83.22
- CV 0.00
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About CV CAPSOVISION INC
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.